Human immunodeficiency virus‐associated plasmablastic lymphoma
Jorge J. Castillo(Dana-Farber Cancer Institute), Julie M. Vose(University of Nebraska Medical Center), Weina Chen(Army Medical University), Michael Furman(Brown University), Nahid Nanaji(University of Maryland, Baltimore), José‐Tomás Navarro(Universitat Autònoma de Barcelona), José L. Díez‐Martín(Universidad Complutense de Madrid), Brady Beltrán(Universidad de San Martín de Porres), Roberto N. Miranda(The University of Texas MD Anderson Cancer Center), Mark Bower(Chelsea and Westminster Hospital), Michele Bibas(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Adam C. Seegmiller(Vanderbilt University Medical Center), Jane J. Liu(Sema4 (United States)), Silvia Montoto(Queen Mary University of London)
Cited by 178
Related Papers
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells
|New England Journal of Medicine|2004|1.4k
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
|Nature Medicine|2015|1.1k
Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma
|The Journal of Experimental Medicine|2003|1.1k